Bioventus Inc (NASDAQ: BVS) is -8.76% lower on its value in year-to-date trading and has touched a low of $3.90 and a high of $14.38 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The BVS stock was last observed hovering at around $9.55 in the last trading session, with the day’s gains setting it 0.03%.
Currently trading at $9.58, the stock is -10.17% and -16.42% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.44 million and changing 0.31% at the moment leaves the stock 10.97% off its SMA200. BVS registered 93.54% gain for a year compared to 6-month gain of 62.65%. The firm has a 50-day simple moving average (SMA 50) of $11.5348 and a 200-day simple moving average (SMA200) of $8.6122.
The stock witnessed a -17.98% loss in the last 1 month and extending the period to 3 months gives it a -17.34%, and is -8.76% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.45% over the week and 4.89% over the month.
Bioventus Inc (BVS) has around 970 employees, a market worth around $777.46M and $555.06M in sales. Fwd P/E is 16.96. Profit margin for the company is -7.11%. Distance from 52-week low is 145.64% and -33.38% from its 52-week high. The company has generated returns on investments over the last 12 months (-7.87%).
The EPS is expected to grow by 1910.33% this year
183.0 institutions hold shares in Bioventus Inc (BVS), with institutional investors hold 78.97% of the company’s shares. The shares outstanding are 65.34M, and float is at 44.70M with Short Float at 2.18%. Institutions hold 69.85% of the Float.
The top institutional shareholder in the company is ESSEX WOODLANDS MANAGEMENT, INC. with over 13.02 million shares valued at $74.87 million. The investor’s holdings represent 20.5448 of the BVS Shares outstanding. As of 2024-06-30, the second largest holder is JUNIPER INVESTMENT COMPANY, LLC with 6.83 million shares valued at $39.29 million to account for 10.7823 of the shares outstanding. The other top investors are NANTAHALA CAPITAL MANAGEMENT, LLC which holds 5.34 million shares representing 8.4227 and valued at over $30.7 million, while BLACKROCK INC. holds 3.7415 of the shares totaling 2.37 million with a market value of $13.64 million.
Bioventus Inc (BVS) Insider Activity
The most recent transaction is an insider sale by Singleton Mark Leonard, the company’s SVP & CFO. SEC filings show that Singleton Mark Leonard sold 10,733 shares of the company’s common stock on Dec 23 ’24 at a price of $10.53 per share for a total of $0.11 million. Following the sale, the insider now owns 0.11 million shares.
Bioventus Inc disclosed in a document filed with the SEC on Dec 23 ’24 that CHURCH KATRINA J (SVP & Chief Compliance Officer) sold a total of 2,535 shares of the company’s common stock. The trade occurred on Dec 23 ’24 and was made at $10.53 per share for $26694.0. Following the transaction, the insider now directly holds 47264.0 shares of the BVS stock.
Still, SEC filings show that on Dec 23 ’24, D’Adamio Anthony (SVP & General Counsel) disposed off 5,848 shares at an average price of $10.53 for $61579.0. The insider now directly holds 109,578 shares of Bioventus Inc (BVS).
